Public consultation on proposed amendments to the Poisons Standard - ACMS & Joint ACMS-ACCS, June 2025

Feedback updated 17 Jul 2026

We asked

From 17 April 2025 to 21 May 2025, we sought submissions from the public on scheduling proposals referred to the June 2025 meetings of the Advisory Committees on Medicines and Chemicals Scheduling. Respondents were given the choice to indicate their support or opposition to the proposed amendments using survey buttons, with or without a written response.

You said

We received a total of 620 submissions in response to the pre-meeting public notice for June 2025. The breakdown of the responses has been provided below:

 

ADRENALINE: 173 responses were received, 1 in opposition, 16 in partial support and 156 in full support of the proposed amendments. Of the total responses, 7 provided a written response: 4 in support, 2 in partial support and 1 in opposition.

 

PSILOCYBINE: 609 responses were received, 4 in opposition, 4 in partial support and 601 in full support of the proposed amendments. Of the total responses, 327 provided a written response: 320 in support, 4 in partial support and 3 in opposition.

 

6-METHYLNICOTINE: 163 responses were received, 1 in opposition, 14 in partial support and 148 in full support of the proposed amendments. Of the total responses, 9 provided a written response: 7 in support and 2 in partial support. No written response was received in opposition.

 

AZELAIC ACID: 161 responses were received, 2 in opposition, 19 in partial support and 140 in full support of the proposed amendments. Of the total responses, 10 provided a written response: 6 in support, 2 in partial support and 2 in opposition.

 

EXTRACTS AND ESSENTIAL OILS PRIMARILY COMPOSED OF METHYL SALICYLATE: Two options for change were proposed and a total of 153 responses were received of which 128 were supportive, 22 partially supportive (including support either Option 1 or 2 with caveats) and 3 opposed both the options. Of the total responses, 6 provided written responses supporting and/or opposing one option over the other.

 

  • OPTION 1 (including a cross reference for each substance to the current methyl salicylate entry): 112 responses were in full support, 13 in partial support and 4 in opposition. Of the total responses, 5 provided a written response: 2 in support, 1 in partial support and 2 in opposition.

 

  • OPTION 2 (creating separate new entries for each substance containing methyl salicylate under Schedule 5 and 6): 15 responses were in full support, 6 in partial support and none in opposition. Of the total responses, 3 provided a written response: 1 in support and 2 in partial support.

We did

The Delegate considered all submissions prior to making an interim decision on these proposals. The interim decision on the proposed amendment to the Poisons Standard in regard to PSILOCYBINE was published on 29 May 2026. The interim decisions on all the other proposed amendments were published on 9 June 2026.

Published responses

View submitted responses where consent has been given to publish the response.

Closed 21 May 2025

Opened 17 Apr 2025

Contact

Medicines Scheduling

1800 020 653

medicines.scheduling@health.gov.au

Overview

Scheduling amendments referred to expert advisory committee

This consultation is for applications and delegate initiated proposals to amend the Poisons Standard. The scheduling amendments and any submissions received will be considered at the June 2025 meeting of the Advisory Committee on Medicines Scheduling (ACMS) and the Joint Meeting of ACMS and the Advisory Committee on Chemicals Scheduling (ACCS).

The closing date for this consultation is close of business 21 MAY 2025. All submissions received by the deadline will be considered by the delegate before they make an interim decision.

The proposals under consultation are detailed in the public notice of JUNE 2025. 

Substances for which public comment is sought:

ACMS:

  • Adrenaline
  • Psilocybine
  • 6-Methylnicotine

Joint meeting of ACMS-ACCS:

  • Azelaic acid
  • Extracts and essential oils primarily composed of methyl salicylate

What happens next

All public submissions will be published on the TGA website at Public submissions on scheduling matters, unless marked confidential or indicated otherwise in the submission information (see Privacy and your Personal information).

Public submissions are an important part of the process for amending the Poison Standard, and are published on the TGA website using the consultation hub.  Submissions by the public may not reflect the views of the Department of Health and Aged Care or TGA.  Published submissions should not be taken as being endorsed by the Department or TGA.

Following consideration of public submissions received before the closing date and advice from the expert advisory committee/s, decisions on the proposed amendments are anticipated to be published as interim decisions on the TGA website: Scheduling delegate's interim decisions & invitations for further comment at a later date. 

Audiences

  • Anyone from any background

Interests

  • Scheduling/Poisons standard